This morning’s decision in Helsinn Healthcare v. Teva Pharmaceuticals, the Supreme Court’s first patent case of the year, breaks no new ground. Justice Clarence Thomas’ opinion for a unanimous court holds that Congress’ 2011 revisions to the Patent Act, however important they might be in some areas, did not displace the long-standing rule that commercial … Continue reading Opinion analysis: Justices affirm ruling that secret sales of invention bar later patent